13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
ISSUER PROFILE · CIK 0001178670

Alnylam Pharmaceuticals IncALNY

1 13D/G filings 1 distinct filers 0 insider transactions (365d)

Cross-Reference Snapshot

Activist filings
1
1 SCHEDULE 13G
Distinct filers
1
single filer
Insiders (365d)
0
0 buys · 0 sales
Latest short DTC
5.10
as of 2026-10-15

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $4.41M
Point72 Asset Mgmt

13D/G Filings Timeline · 1 total

FiledFormFilerStakeSharesIntent
2026-10-30 SCHEDULE 13G VANGUARD PORTFOLIO MANAGEMENT LLC — — view →

FINRA Short Interest History

SettlementShort InterestDays to Cover% Δ vs prior
2026-10-15 6,568,786 5.10 -14.8%
2026-09-30 7,711,495 6.45 +7.2%
2026-09-15 7,194,097 4.13 +13.5%
2026-08-31 6,340,087 3.90 +32.9%
2026-08-14 4,770,978 2.36 -0.7%
2026-07-31 4,803,194 2.18 -16.8%
2026-07-15 5,773,373 3.24 -0.5%
2026-06-30 5,799,788 4.22 +6.7%
2026-06-15 5,437,337 4.76 +2.6%
2026-05-29 5,300,015 5.78 -1.8%
2026-05-15 5,398,804 5.13 +13.1%
2026-04-30 4,773,214 4.02 -5.2%

Alert me when any activist files on Alnylam Pharmaceuticals Inc

Free. We email you when criteria match. One-click unsubscribe in every email.

Track every activist who touches this name.

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →